Table 2.
Participants’ functional constipation symptoms and quality of life at baseline.
| Characteristics | Synbiotics (n = 42) | Placebo (n = 42) | p-Value |
|---|---|---|---|
| Functional constipation symptoms | |||
| Defecation frequency φ | |||
| Baseline week-1 | 2.7 ± 1.1 | 3.1 ± 1.0 | 0.148 |
| Baseline week-2 | 2.9 ± 1.2 | 3.2 ± 1.3 | 0.268 |
| BSF scale φ | 2.3 ± 0.9 | 2.6 ± 1.3 | 0.352 |
| PAC-SYM score φ | 1.40 ± 0.72 | 17.93 ± 7.76 | 0.525 |
| Quality of life | |||
| PAC-QOL score φ | 1.53 ± 0.67 | 35.8 ± 16.9 | 0.736 |
BSF: Bristol Stool Form; PAC-SYM: Patients Assessment on Constipation Symptoms, and PAC-QOL: Patients Assessment of Constipation Quality of Life. φ Values are expressed as mean ± standard deviation.